T-cell prolymphocytic leukemia future or investigational therapies

Revision as of 17:03, 30 August 2015 by Jyostna Chouturi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

T-cell prolymphocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating T-cell Prolymphocytic Leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

T-cell prolymphocytic leukemia future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of T-cell prolymphocytic leukemia future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on T-cell prolymphocytic leukemia future or investigational therapies

CDC on T-cell prolymphocytic leukemia future or investigational therapies

T-cell prolymphocytic leukemia future or investigational therapies in the news

Blogs on T-cell prolymphocytic leukemia future or investigational therapies

Directions to Hospitals Treating T-cell prolymphocytic leukemia

Risk calculators and risk factors for T-cell prolymphocytic leukemia future or investigational therapies

References

Template:WH Template:WS